NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

dr_low or Inquirig,

Thanks for asking. Please consider doing your own research by reviewing publicly available information—the same information that is available to us is the same information that is available to you or anyone else. It is best to consider that information in full context and first-hand.

You’re not adding anything substantive to the conversation—you’re only repeating small shards of shiny half-truths while adding in terse innuendo or defamatory comments. In other words, you’re spreading rumors.



It is advisable to avoid disinformation on social media. Do your own research and consult professionals. You might begin by researching Doctors Liau and Ashkan who led the P3. Liau and Ashkan both are extremely noteworthy as we look back on the P3 and as we look forward to the regulatory phase in the UK, US, and other nations…

UCLA, King’s College, JAMA Oncology, and Brown University are some excellent sources that you might wish to consider in reference to the reputation of Northwest Biotherapeutics and those who choose to associate with the company, its SAB, and with the novel DCVax® technology.

The world-renowned doctors cited below worked on the P3 and were coauthors of a DCVax-L publication along with Dr. Bosch of Northwest Biotherapeutics.

Furthermore, both Liau and Ashkan have had the support their respective nations’ governments over many years. Ashkan is an advisor to the UK government, and Liau’s work has been supported by NIH peer-reviewed grants for 20 consecutive years.

https://www.kch.nhs.uk/news/kings-team-wins-professional-excellence-award/


https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html


https://labusinessjournal.com/healthcare/national-academy-medicine-taps-ucla-neurosurgeon/


https://pubmed.ncbi.nlm.nih.gov/33789235/

https://www.societyns.org/about/officers-detail/linda-m-liau-md-phd-mba-4

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

#dcvax #allsolidtumors $nwbo #gbm

Great to see, congratulations Linda Liau winning the Charles B. Wilson Excellence Award 2023:

Established by the Brain Tumor Society in 2004, this award recognizes outstanding contributions of a clinician to the field of neuro-oncology.… pic.twitter.com/6L7rhyoNU4

— Peter Davis (@peter_brit) October 3, 2023

https://hotb.org/wp-content/uploads/2022/05/spore-article-for-donors-4.18.22.pdf

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://www.uclahealth.org/news/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020




https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173767666